BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Art Pappas will be a panelist at the Small and Emerging Private Equity Manager Conference, organized by Credit Suisse's Customized Fund Investment Group, in Houston.
News | 04. 19. 2007
